Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Peptide protocols represent a real investment — in time, in money, and in your biology. Before that investment is made, there is a question most people never think to ask: does my genetic profile suggest my body is positioned to respond to the peptides I'm considering?

The answer isn't in a forum. It isn't in a practitioner's general experience. It's in your DNA — and it's measurable.

Genetic peptide testing is the analysis of specific DNA variants, called single nucleotide polymorphisms (SNPs), that influence how your biology interacts with peptide pathways. The PlexusDx Precision Peptide Genetic Test delivers that analysis through the Peptide Pathways Report: 150 genetic insights across 14 health pathways and 49 peptides, built to give you and your healthcare provider a precision foundation before a single protocol decision is made.

Why Peptides Don't Work the Same Way for Everyone

Peptides are short chains of amino acids that function as biological messengers — binding to receptors, triggering signaling cascades, and directing cells to perform specific functions. The problem with standard peptide protocols is embedded in that mechanism: the receptors, enzymes, and signaling proteins that peptides interact with are encoded by genes. And genes vary.

Two people on the same peptide at the same dose can have measurably different outcomes — not because of lifestyle, effort, or timing, but because their underlying genetic variants create a different biological environment for that peptide to work within.

Five examples drawn directly from the Peptide Pathways Report illustrate how specifically this plays out:

  • ⚖️ Weight Management (33 genetic insights): FTO rs9939609 is one of the most replicated metabolic variants in human genetics, associated with differences in fat storage tendency and satiety signaling efficiency. Your FTO status shapes the metabolic baseline within which GLP-1 class peptides like semaglutide and tirzepatide operate — making it directly relevant context before or during use of these compounds.
  • 🧠 Cognition (6 genetic insights): BDNF rs6265, known as the Val66Met variant, influences how efficiently the brain releases brain-derived neurotrophic factor — a master regulator of neuroplasticity, learning, and memory consolidation. This SNP appears across multiple pathways in the report and is central to understanding how cognitive peptides like Semax and Dihexa interact with your specific brain biology.
  • 💪 Muscle Growth (15 genetic insights): MSTN rs1805086 encodes myostatin, a protein that naturally limits skeletal muscle development. Your variant here shapes how biologically relevant peptides like Follistatin 344, CJC-1295, and IGF-1 LR3 are to your muscle-building goals before you commit to a protocol.
  • Longevity & Aging (17 genetic insights): FOXO3 rs2802292 is among the most studied variants in human longevity science, statistically overrepresented in centenarian populations and associated with enhanced cellular stress resistance and autophagy regulation. It appears across the longevity, skin health, and immunity pathways — relevant to peptides including Epitalon, FOXO4-DRI, OS-01, and Thymalin.
  • 🌙 Sleep (3 genetic insights): CLOCK rs1801260 governs your internal circadian rhythm at the genetic level. Variants here can affect sleep architecture — determining how relevant DSIP (Delta Sleep-Inducing Peptide) may be to your specific biology rather than the average population's response.

None of this is visible from the outside. Your genetics don't announce themselves. But they are measurable — and the Peptide Pathways Report makes them actionable.

Know Before You Invest: The Responsible Party Approach

PlexusDx built the Precision Peptide Genetic Test on a principle that most of the peptide industry hasn't yet adopted: the responsible thing is to understand your genetic profile before spending money on a protocol, not after.

This matters more than it might initially sound. Peptide research is increasingly specific about why individual response varies. A 2025 study from Cleveland Clinic researchers, published in Diabetes, Obesity and Metabolism, found that a genetic scoring system based on a single gene could identify individuals up to 82% more likely to respond significantly to GLP-1 medications — and those up to 50% more likely not to lose weight at all on the same medications. The researchers' stated goal: combining genetic scores with personal factors to ensure "the treatment they receive is most likely to work for them."

That is the standard PlexusDx holds itself to — across 14 pathways, 49 peptides, and 150 genetic insights, not just one gene and one peptide class.

The Peptide Pathways Report is not a guarantee of outcome. No genetic test is. But it gives you something the peptide space has been operating without: a biological baseline, built from your actual DNA, that tells you and your provider which pathways your genetics suggest may be most aligned with targeted peptide support — and which ones may not deliver what you're expecting.

Testing before you invest is not overcaution. It is the precision health standard.

What the Precision Peptide Genetic Test Covers

Run on the Illumina Global Screening Array through CLIA-certified laboratories, the Precision Peptide Genetic Test generates 150 genetic insights across 14 health pathways. Every pathway is defined below with its insight count and the peptides mapped within it:

  • ⚖️ Weight Management — 33 insights: Semaglutide, Tirzepatide, Retatrutide, Cagrilintide, Survodutide, Tesamorelin, AOD-9604, Adipotide
  • 💪 Muscle Growth — 15 insights: CJC-1295, IGF-1 LR3, Ipamorelin, Sermorelin, GHRP-2, GHRP-6, Hexarelin, Follistatin 344
  • Longevity & Aging — 17 insights: Epitalon, FOXO4-DRI, Glutathione, Humanin, Vilon
  • 🌿 Skin Health — 14 insights: GHK-Cu, Matrixyl, OS-01, SNAP-8, Melanotan-1
  • Energy Metabolism — 12 insights: MOTS-C, SS-31
  • 🛡️ Immunity — 11 insights: LL-37, Thymalin, Thymosin Alpha-1
  • 🔧 Tissue Repair — 9 insights: BPC-157, TB-500, MGF, PEG-MGF
  • 😊 Mood — 8 insights: Selank, PE-22-28, Oxytocin
  • 🧠 Cognition — 6 insights: Semax, Dihexa
  • 🔥 Inflammation — 6 insights: KPV, VIP
  • ❤️ Reproductive Health — 6 insights: Gonadorelin, Kisspeptin, Triptorelin
  • 💑 Sexual Health — 6 insights: Melanotan II, PT-141
  • 🧬 Brain Health — 4 insights: Pinealon
  • 🌙 Sleep — 3 insights: DSIP (Delta Sleep-Inducing Peptide)

Across these 14 pathways, the report analyzes 57 unique SNPs across 48 distinct genes. Every variant was selected for its mechanistic relationship to a specific peptide pathway — not a general association with wellness. That distinction matters for the precision of what you receive.

How the Peptide Pathways Report Differs from a Standard DNA Test

Standard genetic wellness tests do one thing: report your variants. They tell you what your genes say — and then stop. What they don't do is translate that information into the context of a specific health goal or intervention.

The Peptide Pathways Report does both. It identifies your variants across 57 SNPs and maps them to the 14 pathways and 49 peptides most researched in the context of those variants. The result is not a data file — it is a precision health roadmap organized around what you're actually trying to accomplish.

To be direct about scope: the report is an educational and optimization tool. It identifies biological alignment and provides pathway-level intelligence. It is not a prescription, and it does not tell you which peptides to take. What it does is ensure that when you and your healthcare provider have that conversation, both of you are starting from your actual genetic data rather than population averages.

Because your DNA never changes, the Peptide Pathways Report is a one-time test. The 150 genetic insights it delivers are as relevant in five years as they are today — applicable across every protocol decision you make for the rest of your health journey.

Who Is This Test For?

The Precision Peptide Genetic Test is built for anyone engaged in evidence-based health optimization — whether researching peptides for the first time or already mid-protocol and trying to understand why results look the way they do. No background in genetics required. Results are delivered through the secure PlexusDx Results Portal with clear, contextualized explanations written for a health-curious non-expert.

The test is especially relevant if you are:

  • 🔬 Researching or currently using GLP-1 class peptides and want to understand the genetic context before or alongside that protocol
  • 🔬 Working with a practitioner on a peptide approach and want to give that conversation a foundation in your actual biology
  • 🔬 Focused on any of the 14 pathways — longevity, cognition, body composition, recovery, mood, immunity, skin health, sleep, or reproductive and sexual health
  • 🔬 Trying to understand why your results from a current protocol differ from what you expected — or from what others with similar goals have reported
  • 🔬 Committed to the principle that a health investment this significant deserves a genetic baseline first

Frequently Asked Questions About Genetic Peptide Testing

What is genetic peptide testing?

Genetic peptide testing analyzes the specific DNA variants (SNPs) that influence how your body interacts with different peptide pathways. The PlexusDx Precision Peptide Genetic Test delivers 150 genetic insights across 14 health pathways and 49 peptides through the Peptide Pathways Report — giving you a personalized, data-driven foundation for every peptide protocol decision.

Why should I test my genetics before starting a peptide protocol?

Peptide protocols are a meaningful investment, and emerging research is increasingly clear that individual genetic variation is a primary driver of why people on the same protocol experience different results. Knowing your genetic profile across 14 pathways and 49 peptides before you begin — rather than discovering it through trial and error — is the precision health standard. It is also the responsible one.

How is the Peptide Pathways Report different from a standard DNA test?

Standard genetic tests report your variants and stop there. The Peptide Pathways Report goes further: it maps your variants across 57 SNPs and 48 genes to 14 specific health pathways and 49 clinically studied peptides, translating raw genetic data into a precision roadmap for protocol decisions. The depth and peptide-specificity of the analysis is what distinguishes it.

Does the Peptide Pathways Report tell me which peptides to take?

No — and that is an intentional and important distinction. The report provides genetic insights about which of the 14 pathways and 49 peptides your variants suggest may be most or least aligned with your biology. It is an educational and health optimization tool, not a prescription. We recommend working with a qualified healthcare provider for all protocol decisions. The report gives that conversation a genetic foundation it otherwise wouldn't have.

I've already started a peptide protocol — is it too late to test?

Not at all. Your DNA doesn't change, and neither does the value of understanding it. If you are already mid-protocol, the Peptide Pathways Report and its 150 genetic insights can help you and your provider assess whether your current compounds are well-matched to your genetic profile, identify additional pathways you haven't yet addressed, and make more informed decisions about adjusting or expanding your approach going forward.

Which genes does the Peptide Pathways Report analyze?

The report analyzes 57 SNPs across 48 genes, including FTO, TCF7L2, MC4R, BDNF, MSTN, FOXO3, PPARGC1A, SIRT1, TERT, IGF1, IGF1R, GHSR, TNF, IL10, COL1A1, HLA-DQA1, OXTR, CLOCK, ACTN3, TP53, ADIPOQ, LEPR, and more — each selected for its mechanistic relevance to a specific peptide pathway, backed by peer-reviewed research.

How is the test run and how are results delivered?

The Precision Peptide Genetic Test is run on the Illumina Global Screening Array through CLIA-certified laboratories — the same platform used across clinical genomics. You collect a simple cheek swab at home and return it in a prepaid envelope. Results are delivered securely through the PlexusDx Results Portal, HIPAA-compliant, with your data never sold or shared without your consent. No doctor's visit required to order.

The Precision Peptide Genetic Test and Peptide Pathways Report are designed for wellness education and health optimization — not for the diagnosis, treatment, or prevention of any disease. Always consult a qualified healthcare provider before beginning any peptide protocol.


If the genetic pathways in this post are relevant to your health goals, these are your recommended next steps:

🧬 Genetic Tests:

📄 Genetic Report:

👉 Explore the PlexusDx Education Hub — including our Peptides & GLP-1 section — for more on how your genetics shape your biology across all 14 pathways.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.